Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection
about
Cardiovascular disease in human immunodeficiency virus infected patients: A true or perceived risk?Cardiovascular Complications of HIV in Endemic Countries.HIV-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammationAspartame Intake Relates to Coronary Plaque Burden and Inflammatory Indices in Human Immunodeficiency VirusHIV-1/HAART-Related Lipodystrophy Syndrome (HALS) Is Associated with Decreased Circulating sTWEAK Levels.Non-Classical Monocytes and Monocyte Chemoattractant Protein-1 (MCP-1) Correlate with Coronary Artery Calcium Progression in Chronically HIV-1 Infected Adults on Stable Antiretroviral TherapyPlasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors.Loss of intraepidermal nerve fiber density during SIV peripheral neuropathy is mediated by monocyte activation and elevated monocyte chemotactic proteins.Changes in oxidized lipids drive the improvement in monocyte activation and vascular disease after statin therapy in HIV.Persistent Immune Activation and Carotid Atherosclerosis in HIV-Infected Ugandans Receiving Antiretroviral Therapy.Immune activation and cardiovascular disease in chronic HIV infection.Inflammation, immune activation, and cardiovascular disease in HIV.Extra-coronary calcification (aortic valve calcification, mitral annular calcification, aortic valve ring calcification and thoracic aortic calcification) in HIV seropositive and seronegative men: Multicenter AIDS Cohort Study.Pathophysiology and management of cardiovascular disease in patients with HIVHIV Infection and Carotid Artery Intima-media Thickness: Pooled Analyses Across 5 Cohorts of the NHLBI HIV-CVD Collaborative.Inflammatory Markers Associated With Subclinical Coronary Artery Disease: The Multicenter AIDS Cohort Study.Novel relationships of markers of monocyte activation and endothelial dysfunction with pulmonary dysfunction in HIV-infected persons.Serum oxidized low-density lipoprotein decreases in response to statin therapy and relates independently to reductions in coronary plaque in patients with HIV.Associations between antiretroviral use and subclinical coronary atherosclerosis.Role of T-Cell Dysfunction, Inflammation, and Coagulation in Microvascular Disease in HIV.Pre-treatment with simvastatin prevents the induction of diet-induced atherosclerosis in a rabbit model.Inflammatory monocytes expressing tissue factor drive SIV and HIV coagulopathy.Neurologic Complications in Treated HIV-1 Infection.Subclinical myocyte injury, fibrosis and strain in relationship to coronary plaque in asymptomatic HIV-infected individuals.Direct Targeting of Macrophages With Methylglyoxal-Bis-Guanylhydrazone Decreases SIV-Associated Cardiovascular Inflammation and Pathology.Coronary Artery Disease in HIV-Infected Patients: Downside of Living Longer.Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression.HIV-1-Associated Atherosclerosis: Unraveling the Missing Link.Frailty and subclinical coronary atherosclerosis: The Multicenter AIDS Cohort Study (MACS).Cardiovascular disease risk among women living with HIV in North America and Europe.Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in HIV.Association of Macrophage Inflammation Biomarkers With Progression of Subclinical Carotid Artery Atherosclerosis in HIV-Infected Women and Men.Comprehensive assessment of the arginine pathway and its relationship to inflammation in HIV.Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1-Infected Individuals.Cardiovascular disease risk scores' relationship to subclinical cardiovascular disease among HIV-infected and HIV-uninfected men.Statin modulation of monocyte phenotype and function: implications for HIV-1-associated neurocognitive disorders.Serum Zinc Concentration and C-Reactive Protein in Individuals with Human Immunodeficiency Virus Infection: the Positive Living with HIV (POLH) Study.The Association of Inflammatory Markers With Nonalcoholic Fatty Liver Disease Differs by Human Immunodeficiency Virus Serostatus.HDL Cholesterol Efflux Capacity in Newly Diagnosed HIV and Effects of Antiretroviral Therapy.Soluble CD14 levels in plasma and breastmilk of Malawian HIV+ women: Lack of association with morbidity and mortality in their exposed infants.
P2860
Q26777866-5F7278CE-3FD8-4827-B616-4670EB8B350AQ30244655-1992BFA7-4990-4EB0-A537-616ABD57A0CFQ30839904-575E63F6-0111-4B2C-AD46-DEEB1046FDAAQ33878675-5E4AB401-55CE-49BA-A9F7-F1206E302AF9Q35866999-E60E371C-6F72-4EB4-B287-5FBB938CBB4CQ35921028-12B87D1B-DDD5-454B-8B2D-EB411208E755Q36063953-AD42CA29-71F6-4968-B08E-6BE308E08CC7Q36383524-7B0F771E-DF17-46F0-9994-6FC7610A6360Q36436569-F0B71381-1741-4B4C-9681-B67BDC25FB78Q36440262-787B2DD8-48CD-4F3F-8543-1ADFF8D9652CQ36556082-59C6AB72-E8E3-4CFF-8DB4-495D696326A3Q36957752-29DA4791-2F46-4395-8991-766D425FBB37Q36971255-C7AD3088-E8BE-47C0-9211-73FA4BE5BA1BQ37038775-9FD575DF-FF11-4977-B844-3870A59F4FA5Q37055020-95227D43-1B6F-4BD5-9D15-7C9760A2721BQ37076185-9A6B59C2-6469-4BFD-BA9B-E1167376C8E2Q37102014-0E05D4C2-58D1-41FB-B766-47CF375E2F78Q37294964-5D18824C-E2FD-4399-ACF0-56FF1F05632EQ37520935-3046CDC2-855A-4ACF-A5AE-9D7CDE7E6568Q37556442-FAC7D884-48B7-4959-9FE5-8DA4DEF49493Q37581629-24C895CC-EE92-4EB4-BDC4-E71D0EB77FEAQ38601647-87415388-CD67-481F-A5F8-6FEE41056EA0Q38832560-448684F9-884D-49C5-B586-4E3CE1CE3B13Q38851822-EE370302-4432-430A-A5FE-89B0EFBDB5A6Q38988925-2D8B1E95-B068-440C-9D7A-3492E7801644Q39165028-9EAD8A4C-2B82-4023-8746-85174142B130Q39359637-0A756565-722C-4DA8-AB97-571E7C1D9154Q39392100-4A189E88-8EDB-46E7-90C9-447C68CCFE0DQ40050404-FB969D89-4964-457E-8853-932D978A11F8Q40074176-E45CE58D-06FF-4A09-B8F2-6431B9E7825AQ40311279-6EEFE6BF-1C43-4E4C-84E1-C1504F16BD55Q40332270-334A6FE7-4797-41B0-AB2E-C7AD9916956FQ40421789-A5DB95EC-EDC7-432E-981C-5B54E9642D12Q40632660-423F2A53-134C-48DB-B23E-B9E8E65120B9Q40666123-8D1C8524-7201-46C0-8843-5A753C2699AFQ40738275-490AEFFE-344D-4158-8DBC-5214D9086968Q40969473-3E80A762-ED0C-42B3-8F6C-F6FD55E3B3CFQ41722812-C3EC2F91-B69A-4E2A-B29B-B92F45285AC7Q46224865-124EF6B1-FEDC-4B5E-B37B-51F47E1A6393Q47546312-6D42A283-94C6-4FCC-8F36-A78F1C459E8E
P2860
Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Elevated levels of monocyte ac ...... nd those without HIV infection
@ast
Elevated levels of monocyte ac ...... nd those without HIV infection
@en
type
label
Elevated levels of monocyte ac ...... nd those without HIV infection
@ast
Elevated levels of monocyte ac ...... nd those without HIV infection
@en
prefLabel
Elevated levels of monocyte ac ...... nd those without HIV infection
@ast
Elevated levels of monocyte ac ...... nd those without HIV infection
@en
P2093
P2860
P356
P1476
Elevated levels of monocyte ac ...... nd those without HIV infection
@en
P2093
Frank J Palella
Joseph B Margolick
Lawrence A Kingsley
Lisa P Jacobson
Mallory D Witt
Rebeccah A McKibben
Richard T George
Russell P Tracy
Steven Grinspoon
Todd T Brown
P2860
P304
P356
10.1093/INFDIS/JIU594
P407
P577
2014-10-30T00:00:00Z